Company / CapEx per Share
Biogen CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$1.06
FY2025
5-year range
$1.06 / $1.88
FY2021-FY2025
Trend
-0.6%
vs FY2024
Sector context
#11 of 190
Health Care
What the data says
Among 190 Health Care companies, Biogen is in the top 6% for capex per share. CapEx per Share has fluctuated over the past 10 years, ranging from $1.06 in FY2025 to $4.02 in FY2017.
Based on SEC 10-K filings.
1.06 in FY2025 with a 5-year CAGR of -13.2%. Top quartile in the Health Care sector.
Declined from $1.88 to $1.06 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -12.4%
- 5-Year CAGR
- -13.2%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 190This company $1.06 Sector average $2.49
▼
-57.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 0.6% year-over-year.
- Ranks #11 out of 190 companies in the Health Care sector.
- Peak capex per share was recorded in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.06 | -0.6% |
| FY2024 | $1.07 | -43.4% |
| FY2023 | $1.88 | +19.5% |
| FY2022 | $1.58 | +6.4% |
| FY2021 | $1.48 | -31.2% |
| FY2020 | $2.15 | -11.4% |
| FY2019 | $2.43 | -31.8% |
| FY2018 | $3.57 | -11.2% |
| FY2017 | $4.02 | +42.5% |
| FY2016 | $2.82 | +2.8% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026